Use of antipsychotics and antidepressants in patients with HIV

Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms a...

Full description

Saved in:
Bibliographic Details
Published inEuropean psychiatry Vol. 33; no. S1; pp. S150 - S151
Main Authors Muñoz-Calero, P, García Sánchez, F, Rodriguez Criado, N, Martín Aragón, R, Cruz Fourcade, J.F, Bravo Herrero, S, Sánchez Sánchez, B
Format Journal Article
LanguageEnglish
Published Elsevier Masson SAS 01.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions.
AbstractList Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions.
Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions. Disclosure of interest The authors have not supplied their declaration of competing interest.
Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions.
Author Rodriguez Criado, N
Bravo Herrero, S
Sánchez Sánchez, B
García Sánchez, F
Martín Aragón, R
Cruz Fourcade, J.F
Muñoz-Calero, P
Author_xml – sequence: 1
  fullname: Muñoz-Calero, P
– sequence: 2
  fullname: García Sánchez, F
– sequence: 3
  fullname: Rodriguez Criado, N
– sequence: 4
  fullname: Martín Aragón, R
– sequence: 5
  fullname: Cruz Fourcade, J.F
– sequence: 6
  fullname: Bravo Herrero, S
– sequence: 7
  fullname: Sánchez Sánchez, B
BookMark eNqVkEFOwzAQRS1UJFrgBixygQSPncTOphKqgFaqxILC1nLsiepQkshOQb09DuUCrGb-aP7XzFuQWdd3SMgd0AwolPdthkc_hFPGosooZEzABZmDEDLlhSxmZE4rlqcV5_KKLEJoKQVBaTkny7eASd8kuhtdTDD7fnQmRGl_RxYHjyHENiSuSwY9Opz6bzfuk_Xm_YZcNvoQ8PavXpPd0-NutU63L8-b1cM2NaxgkFasZGUtpRS2rDhUubBVnXPGoJY1Ssosz2lc1UwbsMiLxsgGrKybvABR82uSn2ON70Pw2KjBu0_tTwqomhCoVp0RqAmBoqAigmhbnm0YT_ty6FUw8X6D1nk0o7K9-2-AObjOGX34wBOGtj_6Lr6tQAWmqHqdKE-QoaSUiYLzH6X6fUA
CitedBy_id crossref_primary_10_1186_s13104_019_4398_6
ContentType Journal Article
Copyright 2016
Copyright_xml – notice: 2016
DBID AAYXX
CITATION
DOI 10.1016/j.eurpsy.2016.01.271
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1778-3585
EndPage S151
ExternalDocumentID 10_1016_j_eurpsy_2016_01_271
S0924933816002753
1_s2_0_S0924933816002753
GroupedDBID ---
--K
--M
.1-
.FO
.~1
09C
09E
0R~
0SF
1B1
1P~
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8FI
8FJ
8P~
AABNK
AACTN
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AANRG
AAOAW
AAQXK
AASVR
AAXUO
ABBQC
ABBZL
ABFNM
ABIVO
ABJNI
ABMZM
ABUWG
ABVZP
ABXAU
ABXDB
ACDAQ
ACGFS
ACHQT
ACIUM
ACQPF
ACZWT
ADAZD
ADBBV
ADDNB
ADEZE
ADKIL
ADMUD
ADOVH
ADVJH
ADVLN
AEBAK
AEKER
AENCP
AENEX
AEVXI
AEYHU
AFCTW
AFKRA
AFRHN
AFTJW
AGABE
AGHFR
AGJUD
AGUBO
AGYEJ
AHIPN
AHRGI
AITUG
AJOXV
AJPFC
AJRQY
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQJOH
ASPBG
AVWKF
AZFZN
AZQEC
BENPR
BLXMC
BLZWO
CCPQU
CCQAD
CCUQV
CFBFF
CGQII
CJCSC
CS3
CTKSN
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYUFA
G-Q
GBLVA
GNUQQ
GROUPED_DOAJ
HVGLF
HZ~
IHE
IKXGN
IOO
IPYYG
J1W
LN9
M2M
M41
MO0
N9A
NCXOZ
NZEOI
O-L
O9-
OAUVE
OH0
OK1
OU-
OZT
P-8
P-9
P2P
PC.
PIMPY
PSYQQ
Q38
R2-
RCA
RIG
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
T5K
UHS
UKHRP
UV1
WFFJZ
Z5R
~G-
AAEED
AAQFI
ABYKQ
AEBPU
AFPKN
AJBFU
EFLBG
LCYCR
LW7
AAYXX
CITATION
ID FETCH-LOGICAL-c2521-92626b8887d6931947d9b43221b8be802d340c25a2ac1de35fc8f1d8bf4517b3
IEDL.DBID .~1
ISSN 0924-9338
IngestDate Thu Sep 26 16:14:40 EDT 2024
Fri Feb 23 02:30:52 EST 2024
Tue Oct 15 23:01:34 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2521-92626b8887d6931947d9b43221b8be802d340c25a2ac1de35fc8f1d8bf4517b3
OpenAccessLink https://www.cambridge.org/core/services/aop-cambridge-core/content/view/106663DF136F5AADDDD7E62883DC20C4/S0924933800224759a.pdf/div-class-title-use-of-antipsychotics-and-antidepressants-in-patients-with-hiv-div.pdf
ParticipantIDs crossref_primary_10_1016_j_eurpsy_2016_01_271
elsevier_sciencedirect_doi_10_1016_j_eurpsy_2016_01_271
elsevier_clinicalkeyesjournals_1_s2_0_S0924933816002753
PublicationCentury 2000
PublicationDate March 2016
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: March 2016
PublicationDecade 2010
PublicationTitle European psychiatry
PublicationYear 2016
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
SSID ssj0017006
Score 2.155413
Snippet Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in...
Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with...
Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in...
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S150
SubjectTerms Internal Medicine
Psychiatry
Title Use of antipsychotics and antidepressants in patients with HIV
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0924933816002753
https://dx.doi.org/10.1016/j.eurpsy.2016.01.271
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELaqDogF8RTlUXlgDbUdO48FCVVUBakstKibFceOFIa0ImVg4bdzlzioCMSAlMWRrSSffXe-83cXQq6sASPrWBokMucYuuFBZooMwxwuFMpKZjCgP3uMpgv5sFTLHhl3uTBIq_S6v9Xpjbb2d0YezdG6LEdPDF2HEA--0LdSWPFTgvmDNX398UXzwPJzzXkldA6wd5c-13C8HHxM_Y4ErwiLd4qY_26etkzOZJ_s-b0ivW1f54D0XHVIdmb-NPyI3CxqR1cFBXBKn01V5jU0bXPLk1yR6ELLivoKqjXF0Cud3j8fk_nkbj6eBv5_CEEuFDIpBHgfBlzW2EYpiI6MbWokSCQ3iXEJEzaUDLpmIsu5dSHSswpuE1NIxWMTnpB-tarcKaEgyJESRQruFpOxyo2ACSrgcklhIpUNSNChoNdt1Qvd0cFedIuaRtQ04xpQG5C4g0p3GZ2gg1ztBaLWXNdCM_1j0rZHfpt3DSr9z2ee_XvkOdnFVsskuyD9zeubu4StxcYMm7UzbBzzT_KAzLE
link.rule.ids 315,783,787,867,4509,27936,27937,45597
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZKkYAF8RTlmYE1NHbsPBYkVFGl0HahRd2sOHakMLQVKQMLv527xEFFIAakLHFsxfnsO_vO310IudYKFlnjxW7EM4quG-qmKk_RzWF8JjT3FDr0R-MgmfKHmZi1SK-JhUFapdX9tU6vtLUt6Vo0u8ui6D55aDr4ePCFtpXwN8gmx_0xTOqbjy-eB-afqw4sobaL1Zv4uYrkZeBryndkeAWYvZOF9Pf1aW3N6e-RXbtZdO7q_uyTlpkfkK2RPQ4_JLfT0jiL3AF0ChtOVWQl3OqqyLJckeniFHPHplAtHfS9Osng-YhM-veTXuLaHyK4GRNIpWBgfiiwWUMdxCA7PNSx4iCSVEXKRB7TPvegasrSjGrjIz8rpzpSORc0VP4xac8Xc3NCHJDkQLA8BnvL46HIFIMRyuEyUa4CkXaI26Agl3XaC9nwwV5kjZpE1KRHJaDWIWEDlWxCOkEJmdJKRCmpLJn05I9RW2_5beAl6PQ_33n675ZXZDuZjIZyOBg_npEdfFLTys5Je_X6Zi5gn7FSl9U8-gSIac7j
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+antipsychotics+and+antidepressants+in+patients+with+HIV&rft.jtitle=European+psychiatry&rft.au=Mu%C3%B1oz-Calero%2C+P.&rft.au=Garc%C3%ADa+S%C3%A1nchez%2C+F.&rft.au=Rodriguez+Criado%2C+N.&rft.au=Mart%C3%ADn+Arag%C3%B3n%2C+R.&rft.date=2016-03-01&rft.issn=0924-9338&rft.eissn=1778-3585&rft.volume=33&rft.issue=S1&rft.spage=S150&rft.epage=S151&rft_id=info:doi/10.1016%2Fj.eurpsy.2016.01.271&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_eurpsy_2016_01_271
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09249338%2FS0924933816X00041%2Fcov150h.gif